Press Release

Healthcare Trust of America, Inc. Reports Second Quarter 2017 Earnings

$2.6 Billion in Year-to-Date Investments

Quarter Normalized FFO of $0.39 Per Diluted Share and Same-Property Cash NOI Growth of 3.1%

Company Release - 7/31/2017 4:05 PM ET

SCOTTSDALE, Ariz., July 31, 2017 /PRNewswire/ -- Healthcare Trust of America, Inc. (NYSE: HTA) ("HTA") announced results for the three and six months ended June 30, 2017.

Healthcare Trust of America, Inc. Logo.

Second Quarter 2017 Highlights

Operating

  • Net Income (Loss) Attributable to Common Stockholders: Decreased to $(5.9) million net loss, compared to Q2 2016.  Earnings per diluted share decreased to $(0.03) per diluted share, compared to Q2 2016.  Total revenues increased $26.6 million due to the continued growth in HTA's operations, however, the increase in revenues was primarily offset by the increase in transaction expenses related to second quarter investments, including the loss on extinguishment of debt related to the bridge facility fees paid in connection with the Duke acquisition.
  • Funds From Operations ("FFO"): As defined by the National Association of Real Estate Investment Trusts ("NAREIT"), increased 1.7%, to $54.2 million, compared to Q2 2016.  FFO per diluted share decreased 21.1%, to $0.30 per diluted share, compared to Q2 2016.
  • Normalized FFO: Increased 23.3%, to $69.6 million, compared to Q2 2016.  Normalized FFO per diluted share decreased 2.5%, to $0.39 per diluted share, compared to Q2 2016.
  • Normalized Funds Available for Distribution ("FAD"): Increased 21.1%, to $60.6 million, compared to Q2 2016.
  • Same-Property Cash Net Operating Income ("NOI"): Increased $2.2 million, or 3.1%, to $75.0 million, compared to Q2 2016.  Same-Property rental revenue increased $1.6 million, or 1.9%, to $85.6 million, compared to Q2 2016.

Portfolio

  • Investments: During the quarter, HTA had investments of $2.6 billion totaling approximately 6.2 million square feet of GLA that were 92% leased as of the date of acquisition and included the following:
    • HTA announced potential investments of $2.75 billion of the Duke Realty medical office business and development platform (collectively, the "Duke Assets"), with $2.2 billion closing during the quarter following the exclusion of 11 properties valued at $494.9 million, primarily subject to rights of first offer and/or rights of first refusal in favor of unrelated third parties.  The Duke Assets totaled approximately 4.9 million square feet of GLA that were 93% leased as of the date of acquisition and 91% of the acquired GLA were located in certain of HTA's 15 to 20 existing key markets.  Of the remaining Duke Assets, three properties closed in July 2017 for an aggregate purchase price of $131.7 million totaling approximately 245,000 square feet of GLA.  The remaining parcel of land for $5.1 million is expected to close in the second half of 2017.
    • In addition, HTA completed investments of $390.5 million totaling approximately 1.3 million square feet of GLA that were 89% leased as of the date of acquisition and located substantially in certain of HTA's 15 to 20 key markets.
  • Development Platform Acquisition: During the quarter, HTA completed its acquisition of Duke's development and construction platform as part of the Duke acquisition.  This best-in-class development platform, renamed HTA-Development, has developed over $1.0 billion in medical real estate assets over the last 10 years.  As part of the transition, HTA also announced the appointment of Keith Konkoli to the newly created position of Executive Vice President - Development.  Mr. Konkoli will be responsible for HTA-Development's national development and construction activities and will lead a team of 15 experienced professionals.
  • Leasing: HTA entered into new and renewal leases on approximately 519,000 square feet of GLA, or 2.2%, of its portfolio.  Tenant retention for the Same-Property portfolio was 78% by GLA for the quarter, which included approximately 544,000 square feet of GLA of expiring leases.  Renewal leases included tenant improvements of $1.51 per square foot per year of the lease term and approximately one week of free rent per year of the lease term.

Capital Markets

  • Equity: During the quarter, HTA issued and sold $1.7 billion of equity comprised of $1.6 billion from the sale of common stock in an underwritten public offering at an average price of $28.50 per share, and $125.7 million from the sale of common stock under the ATM at an average price of $31.45 per share.
  • Debt: In June 2017, HTA issued in a public offering a total of $900.0 million in senior unsecured notes at an average interest rate of 3.4% and an average duration of 7.7 years and consist of $400.0 million of 5-year unsecured senior notes, with a coupon of 2.95% per annum, and $500.0 million of 10-year unsecured senior notes, with a coupon of 3.75% per annum.  HTA also entered into a $286.0 million financing with the seller in the Duke acquisition with a 4.0% per annum interest rate and an outside maturity date in 2021.

Year-to-Date 2017 Highlights

Operating

  • Net Income (Loss) Attributable to Common Stockholders: Decreased to $7.6 million, compared to year-to-date 2016.  Earnings per diluted share decreased to $0.05 per diluted share, compared to year-to-date 2016.  Total revenues increased $43.7 million due to the continued growth in HTA's operations, however, the increase in revenues was primarily offset by the increase in transaction expenses related to second quarter investments, including the loss on extinguishment of debt related to the bridge facility fees paid in connection with the Duke acquisition.
  • FFO: As defined by NAREIT, increased 13.7%, to $114.4 million, compared to year-to-date 2016.  FFO per diluted share decreased 5.4%, to $0.70 per diluted share, compared to year-to-date 2016.
  • Normalized FFO: Increased 19.5%, to $129.8 million, compared to year-to-date 2016.  Normalized FFO per diluted share decreased 1.3% to $0.79 per diluted share, compared to year-to-date 2016.
  • Normalized FAD: Increased 15.0%, to $113.5 million, compared to year-to-date 2016.
  • Same-Property Cash NOI: Increased $4.3 million, or 3.1%, to $144.4 million, compared to year-to-date 2016.  Same-Property rental revenue increased $3.5 million, or 2.2%, to $162.5 million, compared to year-to-date 2016.

Portfolio

  • Investments: HTA completed investments of $2.6 billion, which included a 50% ownership in a unconsolidated joint venture, to acquire medical office buildings and development properties totaling approximately 6.3 million square feet of GLA that were 92% leased as of the date of acquisition.
  • Dispositions: HTA completed the disposition of a medical office building located in Texas for a gross sales price of $5.0 million (approximately 48,000 square feet of GLA).
  • Leasing: HTA entered into new and renewal leases on approximately 1.3 million square feet of GLA, or 5.4%, of its portfolio.  Tenant retention for the Same-Property portfolio was 78% by GLA year-to-date, which included approximately 1.0 million square feet of expiring leases.  Renewal leases included tenant improvements of $1.47 per square foot per year of the lease term and approximately one week of free rent per year of the lease term.
  • Leased Rate: At the end of the quarter, HTA had a leased rate for its portfolio of 92.0% by GLA and 91.6% for its Same-Property portfolio.

Balance Sheet and Capital Markets

  • Balance Sheet: At the end of the quarter, HTA had total leverage of 30.4% measured as debt to market capitalization, and 6.3x measured as debt to Adjusted Earnings before Interest, Taxes, Depreciation and Amortization ("Adjusted EBITDA").  Total liquidity at the end of the quarter was $935.9 million, including $844.5 million of availability under its unsecured revolving credit facility and $91.4 million of cash and cash equivalents.
  • Debt and Equity: During the six months ended June 30, 2017, HTA issued and sold approximately $1.7 billion in equity at an average price of $28.70 per share and issued $1.2 billion in debt.  These transactions were used to substantially finance HTA's 2017 investments and position its investment grade balance sheet for future growth.

Subsequent Events

  • Investments: Subsequent to the end of the quarter, HTA completed investments with an aggregate purchase price of $149.2 million totaling approximately 292,000 square feet of GLA that was 99% leased as of the acquisition date and located substantially in certain of HTA's key markets.
  • Dividends: On July 31 2017, HTA's Board of Directors increased the quarterly dividend run rate by 1.7% to $0.305 per share of common stock, representing an annualized rate of $1.22 per share of common stock.
  • Debt: On July 27, 2017, HTA entered into an amended and restated $1.3 billion unsecured credit agreement which increased the amount available under the unsecured revolving credit facility to $1.0 billion and extended the maturities of the unsecured revolving credit facility to June 30, 2022 and February 1, 2023 for the $300 million unsecured term loan.  The interest rate on the unsecured credit agreement decreased to adjusted LIBOR plus a margin ranging from 0.83% to 1.55% per annum based on HTA's credit rating.  The other existing terms of the unsecured credit agreement before the amendment remained substantially unchanged.

Financial Results - Second Quarter 2017

Rental Income
Rental income increased 23.3% to $139.5 million for the three months ended June 30, 2017, compared to $113.1 million for the three months ended June 30, 2016.

Net Income (Loss)
Net income (loss) decreased to $(5.9) million net loss for the three months ended June 30, 2017, compared to $13.5 million net income for the three months ended June 30, 2016.  Total revenues increased $26.6 million due to the continued growth in HTA's operations, however, the increase in revenues was primarily offset by the increase in transaction expenses related to second quarter investments, including the loss on extinguishment of debt related to the bridge facility fees paid in connection with the Duke acquisition.

FFO
FFO, as defined by NAREIT, was $0.30 per diluted share, or $54.2 million, for the three months ended June 30, 2017, compared to $0.38 per diluted share, or $53.3 million, for the three months ended June 30, 2016.

Normalized FFO
Normalized FFO was $0.39 per diluted share, or $69.6 million, for the three months ended June 30, 2017, compared to $0.40 per diluted share, or $56.5 million, for the three months ended June 30, 2016.

Normalized FAD
Normalized FAD increased 21.1% to $60.6 million, for the three months ended June 30, 2017, compared to $50.1 million for the three months ended June 30, 2016.

NOI
NOI increased 23.3% to $96.4 million for the three months ended June 30, 2017, compared to $78.2 million for the three months ended June 30, 2016.

Same-Property Cash NOI
Same-Property Cash NOI increased $2.2 million, or 3.1%, to $75.0 million, for the three months ended June 30, 2017, compared to $72.8 million for the three months ended June 30, 2016.  Same-Property rental revenue increased $1.6 million, or 1.9%, to $85.6 million for the three months ended June 30, 2017, compared to the three months ended June 30, 2016.

General and Administrative Expenses
General and administrative expenses were $8.5 million for the three months ended June 30, 2017, compared to $6.8 million for the three months ended June 30, 2016.

Interest Expense and Change in Fair Value of Derivative Financial Instruments
The total interest expense and change in fair value of derivative financial instruments for the three months ended June 30, 2017, was $17.9 million, which included $17.9 million of interest expense related to debt and interest rate swaps, and a net gain of $45,000 on the change in the fair value of HTA's derivative financial instruments.

Investment Activity
During the three months ended June 30, 2017, HTA completed investments of  $2.6 billion, including its investment in a unconsolidated joint venture, totaling 6.2 million square feet of GLA that were 92% leased as of the acquisition date.

Tenant Retention
Tenant retention for the Same-Property portfolio was 78% by GLA for the quarter, which included approximately 544,000 square feet of expiring leases. 

Financial Results - Year-to-Date 2017

Rental Income
Rental income increased 19.6% to $263.5 million for the six months ended June 30, 2017, compared to $220.4 million for the six months ended June 30, 2016.

Net Income
Net income decreased to $8.1 million for the six months ended June 30, 2017, compared to $23.6 million for the six months ended June 30, 2016.  Total revenues increased $43.7 million due to the continued growth in HTA's operations, however, the increase in revenues was primarily offset by the increase in transaction expenses related to second quarter investments, including the loss on extinguishment of debt related to the bridge facility fees paid in connection with the Duke acquisition.

FFO
FFO, as defined by NAREIT, was $0.70 per diluted share, or $114.4 million, for the six months ended June 30, 2017, compared to $0.74 per diluted share, or $100.7 million, for the six months ended June 30, 2016.

Normalized FFO
Normalized FFO was $0.79 per diluted share, or $129.8 million, for the six months ended June 30, 2017, compared to $0.80 per diluted share, or $108.6 million, for the six months ended June 30, 2016.

Normalized FAD
Normalized FAD increased 15.0% to $113.5 million, for the six months ended June 30, 2017, compared to $98.7 million for the six months ended June 30, 2016.

NOI
NOI increased 19.5% to $181.7 million for the six months ended June 30, 2017, compared to $152.1 million for the six months ended June 30, 2016.

Same-Property Cash NOI
Same-Property Cash NOI increased $4.3 million, or 3.1%, to $144.4 million, for the six months ended June 30, 2017, compared to $140.1 million for the six months ended June 30, 2016.  Same-Property rental revenue increased $3.5 million, or 2.2%, to $162.5 million, for the six months ended June 30, 2017, compared to the six months ended June 30, 2016.

General and Administrative Expenses
General and administrative expenses were $16.9 million for the six months ended June 30, 2017, compared to $13.6 million for the six months ended June 30, 2016.

Interest Expense and Change in Fair Value of Derivative Financial Instruments
The total interest expense and change in fair value of derivative financial instruments for the six months ended June 30, 2017, was $33.4 million, which included $34.3 million of interest expense related to debt and interest rate swaps, and a net gain of $0.9 million on the change in the fair value of HTA's derivative financial instruments. 

HTA ended the quarter with a weighted average interest rate of 3.47% per annum, including the impact of interest rate swaps.  The weighted average remaining term of HTA's total debt was 5.9 years, including extension options.

Investment Activity
During the six months ended June 30, 2017, HTA completed investments of $2.6 billion, including its investment in a unconsolidated joint venture, totaling 6.3 million square feet of GLA that were 92% leased as of the acquisition date.

Leased Rate, Occupancy Rate and Tenant Retention
The leased rate (includes leases which have been executed, but which have not yet commenced) was 92.0% by GLA as of June 30, 2017.  The occupancy rate of HTA's portfolio was 91.1% by GLA as of June 30, 2017.  Tenant retention for the Same-Property portfolio was 78% by GLA year-to-date, which included approximately 1.0 million square feet of expiring leases. 

Credit Rated Tenants
Investment grade rated tenants as a percent of annualized base rent was 46% as of June 30, 2017.  Additionally, 61% of HTA's annualized base rent as of June 30, 2017 was derived from tenants that have (or whose parent companies have) a credit rating from a nationally recognized rating agency.

In-House Property Management and Leasing Platform
As of June 30, 2017, HTA's in-house property management and leasing platform operated approximately 22.4 million square feet of GLA, or 93%, of HTA's total portfolio.

Balance Sheet
As of June 30, 2017, HTA had total assets of $6.4 billion, cash and cash equivalents of $91.4 million, and $844.5 million available under its unsecured revolving credit facility (includes the impact of $5.5 million of outstanding letters of credit).  The leverage ratio of debt to market capitalization was 30.4% as of June 30, 2017.

About Healthcare Trust of America, Inc.
Healthcare Trust of America, Inc. (NYSE: HTA) is the largest dedicated owner and operator of medical office buildings ("MOBs") in the United States, based on gross leasable area ("GLA").  We provide the real estate infrastructure for the integrated delivery of healthcare services in highly desirable locations.  Over the last decade, we have invested $6.8 billion primarily in MOBs and other healthcare assets comprising 24.0 million square feet of GLA.  Our investments are targeted in 15 to 20 key markets that we believe have superior healthcare demographics that support strong, long-term demand for medical office space.  We have achieved, and continue to achieve, critical mass within these key markets by expanding our presence through accretive acquisitions, and utilizing our in-house operating expertise through our regionally located property management and leasing platform.

Founded in 2006 and listed on the New York Stock Exchange in 2012, HTA has produced attractive returns for its stockholders that we believe have significantly outperformed the S&P 500 and US REIT indices.  More information about HTA can be found on the Company's website at www.htareit.com.

Forward-Looking Language
This press release contains certain forward-looking statements with respect to HTA.  Forward-looking statements are statements that are not descriptions of historical facts and include statements regarding management's intentions, beliefs, expectations, plans or predictions of the future, within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  Because such statements include risks, uncertainties and contingencies, actual results may differ materially and in adverse ways from those expressed or implied by such forward-looking statements.  These risks, uncertainties and contingencies include, without limitation, the following: changes in economic conditions generally and the real estate market specifically; legislative and regulatory changes, including changes to laws governing the taxation of REITs and changes to laws governing the healthcare industry; the availability of capital; changes in interest rates; competition in the real estate industry; the supply and demand for operating properties in our proposed market areas; changes in accounting principles generally accepted in the United States of America; policies and guidelines applicable to REITs; the availability of properties to acquire; and the availability of financing.  Additional information concerning us and our business, including additional factors that could materially and adversely affect our financial results, include, without limitation, the risks described under Part I, Item 1A - Risk Factors, in our Annual Report on Form 10-K and in our filings with the SEC.

Conference Call
HTA will host a conference call and webcast on Tuesday, August 1, 2017 at 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time) to review its financial performance and operating results for the three and six months ended June 30, 2017.

Conference Call and Webcast Details:
Domestic Dial-In Number: (877) 507-6265
International Dial-In Number: (412) 902-6633
Canada Dial-In Number: (855) 669-9657
Webcast: www.htareit.com under the Investor Relations tab

Replay Conference Call Details:
Domestic Dial-In Number: (877) 344-7529
International Dial-In Number: (412) 317-0088
Canada Dial-In Number: (855) 669-9658
Conference ID: 10109677
Available August 1, 2017 (one hour after the end of the conference call) to September 1, 2017 at 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time)

Supplemental Information
Supplemental financial data are available on the HTA's website at www.htareit.com.

HEALTHCARE TRUST OF AMERICA, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

(Unaudited)




June 30, 2017


December 31, 2016

ASSETS





Real estate investments:





Land


$

461,340



$

386,526


Building and improvements


5,699,968



3,466,516


Lease intangibles


635,330



467,571


Construction in progress


251






6,796,889



4,320,613


Accumulated depreciation and amortization


(907,728)



(817,593)


Real estate investments, net


5,889,161



3,503,020


Investment in unconsolidated joint venture


68,901




Cash and cash equivalents


91,444



11,231


Restricted cash and escrow deposits


33,176



13,814


Receivables and other assets, net


175,340



173,461


Other intangibles, net


108,736



46,318


Total assets


$

6,366,758



$

3,747,844


LIABILITIES AND EQUITY





Liabilities:





Debt


$

2,784,162



$

1,768,905


Accounts payable and accrued liabilities


135,214



105,034


Derivative financial instruments - interest rate swaps


1,569



1,920


Security deposits, prepaid rent and other liabilities


55,286



49,859


Intangible liabilities, net


78,779



37,056


Total liabilities


3,055,010



1,962,774


Commitments and contingencies





Redeemable noncontrolling interests


4,663



4,653


Equity:





Preferred stock, $0.01 par value; 200,000,000 shares authorized; none issued and outstanding





Class A common stock, $0.01 par value; 1,000,000,000 shares authorized; 200,646,523 and 141,719,134 shares issued and outstanding as of June 30, 2017 and December 31, 2016, respectively


2,006



1,417


Additional paid-in capital


4,384,483



2,754,818


Accumulated other comprehensive loss


(816)




Cumulative dividends in excess of earnings


(1,164,607)



(1,068,961)


Total stockholders' equity


3,221,066



1,687,274


Noncontrolling interests


86,019



93,143


Total equity


3,307,085



1,780,417


Total liabilities and equity


$

6,366,758



$

3,747,844


 

HEALTHCARE TRUST OF AMERICA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

(Unaudited)



Three Months Ended June 30,


Six Months Ended June 30,


2017


2016


2017


2016

Revenues:








Rental income

$

139,525



$

113,144



$

263,518



$

220,394


Interest and other operating income

354



90



708



155


Total revenues

139,879



113,234



264,226



220,549


Expenses:








Rental

43,523



35,061



82,543



68,414


General and administrative

8,472



6,813



16,895



13,586


Transaction

5,073



2,062



5,357



3,875


Depreciation and amortization

55,353



44,738



102,409



82,566


Impairment

5,093





5,093




Total expenses

117,514



88,674



212,297



168,441


Income before other income (expense)

22,365



24,560



51,929



52,108


Interest expense:








Interest related to derivative financial instruments

(239)



(659)



(563)



(1,304)


Gain (loss) on change in fair value of derivative financial instruments, net

45



(658)



884



(3,450)


Total interest related to derivative financial instruments, including net change in fair value of derivative financial instruments

(194)



(1,317)



321



(4,754)


Interest related to debt

(17,706)



(13,989)



(33,764)



(28,117)


Gain on sale of real estate, net



4,212



3



4,212


Loss on extinguishment of debt, net

(10,386)



(22)



(10,418)



(22)


Income from unconsolidated joint venture

63





63




Other income

6



72



14



125


Net (loss) income

$

(5,852)



$

13,516



$

8,148



$

23,552


Net income attributable to noncontrolling interests

(66)



(442)



(521)



(618)


Net (loss) income attributable to common stockholders

$

(5,918)



$

13,074



$

7,627



$

22,934


Earnings per common share - basic:








Net (loss) income attributable to common stockholders

$

(0.03)



$

0.10



$

0.05



$

0.17


Earnings per common share - diluted:








Net (loss) income attributable to common stockholders

$

(0.03)



$

0.09



$

0.05



$

0.17


Weighted average common shares outstanding:








Basic

176,464



136,528



159,218



132,932


Diluted

176,464



140,512



163,490



135,876


Dividends declared per common share

$

0.300



$

0.295



$

0.600



$

0.590


 

HEALTHCARE TRUST OF AMERICA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)



Six Months Ended June 30,


2017


2016

Cash flows from operating activities:




Net income

$

8,148



$

23,552


Adjustments to reconcile net income to net cash provided by operating activities:




Depreciation, amortization and other

100,536



81,362


Share-based compensation expense

3,839



3,033


Bad debt expense

227



386


Impairment

5,093




Income from unconsolidated joint venture

(63)




Gain on sale of real estate, net

(3)



(4,212)


Loss on extinguishment of debt, net

10,418



22


Change in fair value of derivative financial instruments

(884)



3,450


Changes in operating assets and liabilities:




Receivables and other assets, net

(2,969)



(667)


Accounts payable and accrued liabilities

14,272



(5,983)


Security deposits, prepaid rent and other liabilities

1,907



(4,543)


Net cash provided by operating activities

140,521



96,400


Cash flows from investing activities:




Investments in real estate

(2,202,815)



(336,760)


Investment in unconsolidated joint venture

(68,839)




Development of real estate

(348)




Proceeds from the sale of real estate

4,746



23,368


Capital expenditures

(26,022)



(21,826)


Restricted cash, escrow deposits and other assets

(19,362)



(426)


Net cash used in investing activities

(2,312,640)



(335,644)


Cash flows from financing activities:




Borrowings on unsecured revolving credit facility

305,000



336,000


Payments on unsecured revolving credit facility

(393,000)



(293,000)


Proceeds from unsecured senior notes

900,000




Payments on secured mortgage loans

(74,319)



(22,791)


Deferred financing costs

(9,400)




Debt extinguishment costs

(10,391)




Security deposits

1,964



765


Proceeds from issuance of common stock

1,624,222



292,984


Repurchase and cancellation of common stock

(3,339)



(2,287)


Dividends paid

(85,683)



(76,018)


Distributions paid to noncontrolling interest of limited partners

(2,722)



(1,331)


Net cash provided by financing activities

2,252,332



234,322


Net change in cash and cash equivalents

80,213



(4,922)


Cash and cash equivalents - beginning of period

11,231



13,070


Cash and cash equivalents - end of period

$

91,444



$

8,148


 

HEALTHCARE TRUST OF AMERICA, INC.

NOI, CASH NOI AND SAME-PROPERTY CASH NOI

(In thousands)

(Unaudited)



Three Months Ended June 30,


Six Months Ended June 30,


2017


2016


2017


2016

Net (loss) income

$

(5,852)



$

13,516



$

8,148



$

23,552


General and administrative expenses

8,472



6,813



16,895



13,586


Transaction expenses (1)

5,073



2,062



5,357



3,875


Depreciation and amortization expense

55,353



44,738



102,409



82,566


Impairment

5,093





5,093




Interest expense and net change in fair value of derivative financial instruments

17,900



15,306



33,443



32,871


Gain on sale of real estate, net



(4,212)



(3)



(4,212)


Loss on extinguishment of debt, net

10,386



22



10,418



22


Other income

(6)



(72)



(14)



(125)


NOI

$

96,419



$

78,173



$

181,746



$

152,135


NOI percentage growth

23.3

%




19.5

%











NOI

$

96,419



$

78,173



$

181,746



$

152,135


Straight-line rent adjustments, net

(1,616)



(1,024)



(2,825)



(2,475)


Amortization of (below) and above market leases/leasehold interests, net and lease termination fees

126



77



32



494


Cash NOI

$

94,929



$

77,226



$

178,953



$

150,154


Notes receivable interest income

(294)





(586)




Non Same-Property Cash NOI

(19,593)



(4,431)



(33,931)



(10,020)


Same-Property Cash NOI (2)

$

75,042



$

72,795



$

144,436



$

140,134


Same-Property Cash NOI percentage growth

3.1

%




3.1

%












(1)

For the three and six months ended June 30, 2017, transaction costs, which have been adjusted to reflect the prospective presentation of the early adoption of ASU 2017-01 as of January 1, 2017, include $4.6 million of compensation and severance payments to Duke employees pursuant to the Duke purchase agreements in connection with the Duke acquisition.

(2)

Same-Property includes 305 and 296 buildings for the three and six months ended June 30, 2017 and 2016, respectively.

NOI is a non-GAAP financial measure that is defined as net income or loss (computed in accordance with GAAP) before: (i) general and administrative expenses; (ii) transaction expenses; (iii) depreciation and amortization expense; (iv) impairment; (v) interest expense and net change in fair value of derivative financial instruments; (vi) gain or loss on sales of real estate; (vii) gain or loss on extinguishment of debt; and (viii) other income or expense.  HTA believes that NOI provides an accurate measure of the operating performance of its operating assets because NOI excludes certain items that are not associated with the management of its properties.  Additionally, HTA believes that NOI is a widely accepted measure of comparative operating performance of real estate investment trusts ("REITs").  However, HTA's use of the term NOI may not be comparable to that of other REITs as they may have different methodologies for computing this amount.  NOI should not be considered as an alternative to net income or loss (computed in accordance with GAAP) as an indicator of our financial performance.  NOI should be reviewed in connection with other GAAP measurements.

Cash NOI is a non-GAAP financial measure which excludes from NOI: (i) straight-line rent adjustments and (ii) amortization of below and above market leases/leasehold interests.  Contractual base rent, contractual rent increases, contractual rent concessions and changes in occupancy or lease rates upon commencement and expiration of leases are a primary driver of HTA's revenue performance.  HTA believes that Cash NOI, which removes the impact of straight-line rent adjustments, provides another measurement of the operating performance of its operating assets.  Additionally, HTA believes that Cash NOI is a widely accepted measure of comparative operating performance of REITs.  However, HTA's use of the term Cash NOI may not be comparable to that of other REITs as they may have different methodologies for computing this amount.  Cash NOI should not be considered as an alternative to net income or loss (computed in accordance with GAAP) as an indicator of our financial performance.  Cash NOI should be reviewed in connection with other GAAP measurements.

To facilitate the comparison of Cash NOI between periods, HTA calculates comparable amounts for a subset of its owned properties referred to as "Same-Property".  Same-Property Cash NOI excludes properties which have not been owned and operated by HTA during the entire span of all periods presented, excluding properties intended for disposition in the near term, notes receivable interest income and certain non-routine items.  Same-Property Cash NOI should not be considered as an alternative to net income or loss (computed in accordance with GAAP) as an indicator of our financial performance.  Same-Property Cash NOI should be reviewed in connection with other GAAP measurements.

HEALTHCARE TRUST OF AMERICA, INC.

FFO, NORMALIZED FFO AND NORMALIZED FAD

(In thousands, except per share data)

(Unaudited)



Three Months Ended June 30,


Six Months Ended June 30,


2017


2016


2017


2016

Net (loss) income attributable to common stockholders

$

(5,918)



$

13,074



$

7,627



$

22,934


Depreciation and amortization expense related to investments in real estate

54,968



44,411



101,657



81,932


Gain on sale of real estate, net



(4,212)



(3)



(4,212)


Impairment

5,093





5,093




Proportionate share of joint venture depreciation, amortization and other adjustments

42





42




FFO attributable to common stockholders

$

54,185



$

53,273



$

114,416



$

100,654


Transaction expenses (1)

430



2,062



714



3,875


(Gain) loss on change in fair value of derivative financial instruments, net

(45)



658



(884)



3,450


Loss on extinguishment of debt, net

10,386



22



10,418



22


Noncontrolling income from partnership units included in diluted shares

44



446



469



591


Other normalizing items, net (2)

4,643





4,643



(16)


Normalized FFO attributable to common stockholders

$

69,643



$

56,461



$

129,776



$

108,576


Other income

(6)



(72)



(14)



(125)


Non-cash compensation expense

1,309



1,230



3,839



3,033


Straight-line rent adjustments, net

(1,616)



(1,024)



(2,825)



(2,475)


Amortization of (below) and above market leases/leasehold interests and corporate assets, net

511



413



784



1,153


Deferred revenue - tenant improvement related

(11)



(7)



(11)



(7)


Amortization of deferred financing costs and debt discount/premium, net

853



776



1,639



1,493


Recurring capital expenditures, tenant improvements and leasing commissions

(10,065)



(7,716)



(19,705)



(12,984)


Normalized FAD attributable to common stockholders

$

60,618



$

50,061



$

113,483



$

98,664










Net (loss) income attributable to common stockholders per diluted share

$

(0.03)



$

0.09



$

0.05



$

0.17


FFO adjustments per diluted share, net

0.33



0.29



0.65



0.57


FFO attributable to common stockholders per diluted share

$

0.30



$

0.38



$

0.70



$

0.74


Normalized FFO adjustments per diluted share, net

0.09



0.02



0.09



0.06


Normalized FFO attributable to common stockholders per diluted share

$

0.39



$

0.40



$

0.79



$

0.80










Weighted average diluted common shares outstanding (3)

180,672



140,512



163,490



135,876











(1)

For the three and six months ended June 30, 2017, amounts have been adjusted to reflect the prospective presentation of the early adoption of ASU 2017-01 as of January 1, 2017.

(2)

For the three and six months ended June 30, 2017, other normalizing items include $4.6 million of compensation and severance payments to Duke employees pursuant to the Duke purchase agreements in connection with the Duke acquisition that were included in transaction expenses on HTA's condensed consolidated statements of operations.  In addition, other normalizing items excludes lease termination fees as they are deemed to be generated in the ordinary course of business.

(3)

For the three months ended June 30, 2017 these securities are anti-dilutive on a GAAP basis as a result of HTA's net loss, but are considered dilutive on a non-GAAP basis in periods where we report non-GAAP net income.

HTA computes FFO in accordance with the current standards established by NAREIT.  NAREIT defines FFO as net income or loss attributable to common stockholders (computed in accordance with GAAP), excluding gains or losses from sales of real estate property and impairment write-downs of depreciable assets, plus depreciation and amortization related to investments in real estate, and after adjustments for unconsolidated partnerships and joint ventures.  HTA presents this non-GAAP financial measure because it considers it an important supplemental measure of its operating performance and believes it is frequently used by securities analysts, investors and other interested parties in the evaluation of REITs.  Historical cost accounting assumes that the value of real estate assets diminishes ratably over time.  Since real estate values have historically risen or fallen based on market conditions, many industry investors have considered the presentation of operating results for real estate companies that use historical cost accounting to be insufficient by themselves.  Because FFO excludes depreciation and amortization unique to real estate, among other items, it provides a perspective not immediately apparent from net income or loss attributable to common stockholders.

HTA computes Normalized FFO, which excludes from FFO: (i) transaction expenses; (ii) gain or loss on change in fair value of derivative financial instruments; (iii) gain or loss on extinguishment of debt; (iv) noncontrolling income or loss from partnership units included in diluted shares; and (v) other normalizing items, which include items that are unusual and infrequent in nature.  HTA presents this non-GAAP financial measure because it allows for the comparison of our operating performance to other REITs and between periods on a consistent basis.  HTA's methodology for calculating Normalized FFO may be different from the methods utilized by other REITs and, accordingly, may not be comparable to other REITs.  Normalized FFO should not be considered as an alternative to net income or loss attributable to common stockholders (computed in accordance with GAAP) as an indicator of our financial performance, nor is it indicative of cash available to fund cash needs.  Normalized FFO should be reviewed in connection with other GAAP measurements.

HTA also computes Normalized FAD, which excludes from Normalized FFO: (i) other income or expense; (ii) non-cash compensation expense; (iii) straight-line rent adjustments; (iv) amortization of below and above market leases/leasehold interests and corporate assets; (v) amortization of deferred financing costs and debt premium/discount; and (vi) recurring capital expenditures, tenant improvements and leasing commissions.  HTA believes this non-GAAP financial measure provides a meaningful supplemental measure of our operating performance.  Normalized FAD should not be considered as an alternative to net income or loss attributable to common stockholders (computed in accordance with GAAP) as an indicator of our financial performance, nor is it indicative of cash available to fund cash needs.  Normalized FAD should be reviewed in connection with other GAAP measurements.

Financial Contact:
Robert A. Milligan
Chief Financial Officer
480.998.3478

View original content with multimedia:http://www.prnewswire.com/news-releases/healthcare-trust-of-america-inc-reports-second-quarter-2017-earnings-300496762.html

SOURCE Healthcare Trust of America, Inc.

Investor Search